FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002162404> ?p ?o ?g. }

• W2002162404 endingPage "1647" @default.
• W2002162404 startingPage "1639" @default.
• W2002162404 abstract "Among heat shock proteins, mortalin has been linked to the pathogenesis of Parkinson's disease. In the present work a rat model of Parkinson's disease was used to analyze the expression of striatal proteins and, more specifically, mortalin expression. The possible involvement of mortalin in Parkinson's disease pathogenesis was further investigated by utilizing an electrophysiological approach and pharmacological inhibition of mortalin in both the physiological and the parkinsonian states. Proteomic analysis was used to investigate changes in striatal protein expression in the 6-hydroxydopamine rat model of Parkinson's disease. The electrophysiological effects of MKT-077, a rhodamine-123 analogue acting as an inhibitor of mortalin, were measured by field potential recordings from corticostriatal brain slices obtained from control, sham-operated, and 6-hydroxydopamine-denervated animals. Slices in the presence of rotenone, an inhibitor of mitochondrial complex I, were also analyzed. Proteomic analysis revealed downregulation of mortalin in the striata of 6-hydroxydopamine-treated rats in comparison with sham-operated animals. MKT-077 reduced corticostriatal field potential amplitude in physiological conditions, inducing membrane depolarization and inward current in striatal medium spiny neurons. In addition, we observed that concentrations of MKT-077 not inducing any electrophysiological effect in physiological conditions caused significant changes in striatal slices from parkinsonian animals as well as in slices treated with a submaximal concentration of rotenone. These findings suggest a critical link between mortalin function and mitochondrial activity in both physiological and pathological conditions mimicking Parkinson's disease." @default.
• W2002162404 created "2016-06-24" @default.
• W2002162404 creator A5000824473 @default.
• W2002162404 creator A5012383994 @default.
• W2002162404 creator A5015556586 @default.
• W2002162404 creator A5023053523 @default.
• W2002162404 creator A5037832617 @default.
• W2002162404 creator A5054139154 @default.
• W2002162404 creator A5063100633 @default.
• W2002162404 creator A5068550013 @default.
• W2002162404 creator A5088823694 @default.
• W2002162404 date "2011-05-03" @default.
• W2002162404 modified "2023-10-06" @default.
• W2002162404 title "Mortalin inhibition in experimental Parkinson's disease" @default.
• W2002162404 cites W1539544057 @default.
• W2002162404 cites W1573319238 @default.
• W2002162404 cites W1906945978 @default.
• W2002162404 cites W1954514489 @default.
• W2002162404 cites W1965006448 @default.
• W2002162404 cites W1966443363 @default.
• W2002162404 cites W1969800514 @default.
• W2002162404 cites W1970703181 @default.
• W2002162404 cites W1981017216 @default.
• W2002162404 cites W1981809263 @default.
• W2002162404 cites W1981877057 @default.
• W2002162404 cites W1986623319 @default.
• W2002162404 cites W1990528837 @default.
• W2002162404 cites W1997874814 @default.
• W2002162404 cites W2005447847 @default.
• W2002162404 cites W2016344599 @default.
• W2002162404 cites W2020453531 @default.
• W2002162404 cites W2021602283 @default.
• W2002162404 cites W2026982245 @default.
• W2002162404 cites W2029997649 @default.
• W2002162404 cites W2030050863 @default.
• W2002162404 cites W2030785267 @default.
• W2002162404 cites W2031574763 @default.
• W2002162404 cites W2032421019 @default.
• W2002162404 cites W2033344011 @default.
• W2002162404 cites W2041679645 @default.
• W2002162404 cites W2042504567 @default.
• W2002162404 cites W2045865115 @default.
• W2002162404 cites W2047898830 @default.
• W2002162404 cites W2048981781 @default.
• W2002162404 cites W2054177581 @default.
• W2002162404 cites W2055308573 @default.
• W2002162404 cites W2059577301 @default.
• W2002162404 cites W2063350853 @default.
• W2002162404 cites W2076009173 @default.
• W2002162404 cites W2080194182 @default.
• W2002162404 cites W2080857749 @default.
• W2002162404 cites W2081714450 @default.
• W2002162404 cites W2087812097 @default.
• W2002162404 cites W2092725897 @default.
• W2002162404 cites W2110225954 @default.
• W2002162404 cites W2119375793 @default.
• W2002162404 cites W2127235616 @default.
• W2002162404 cites W2139044993 @default.
• W2002162404 cites W2149336197 @default.
• W2002162404 cites W2152077478 @default.
• W2002162404 cites W2171032298 @default.
• W2002162404 cites W2180488799 @default.
• W2002162404 cites W37005 @default.
• W2002162404 cites W4293247451 @default.
• W2002162404 doi "https://doi.org/10.1002/mds.23647" @default.
• W2002162404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21542017" @default.
• W2002162404 hasPublicationYear "2011" @default.
• W2002162404 type Work @default.
• W2002162404 sameAs 2002162404 @default.
• W2002162404 citedByCount "23" @default.
• W2002162404 countsByYear W20021624042012 @default.
• W2002162404 countsByYear W20021624042013 @default.
• W2002162404 countsByYear W20021624042014 @default.
• W2002162404 countsByYear W20021624042015 @default.
• W2002162404 countsByYear W20021624042016 @default.
• W2002162404 countsByYear W20021624042017 @default.
• W2002162404 countsByYear W20021624042019 @default.
• W2002162404 countsByYear W20021624042022 @default.
• W2002162404 countsByYear W20021624042023 @default.
• W2002162404 crossrefType "journal-article" @default.
• W2002162404 hasAuthorship W2002162404A5000824473 @default.
• W2002162404 hasAuthorship W2002162404A5012383994 @default.
• W2002162404 hasAuthorship W2002162404A5015556586 @default.
• W2002162404 hasAuthorship W2002162404A5023053523 @default.
• W2002162404 hasAuthorship W2002162404A5037832617 @default.
• W2002162404 hasAuthorship W2002162404A5054139154 @default.
• W2002162404 hasAuthorship W2002162404A5063100633 @default.
• W2002162404 hasAuthorship W2002162404A5068550013 @default.
• W2002162404 hasAuthorship W2002162404A5088823694 @default.
• W2002162404 hasBestOaLocation W20021624042 @default.
• W2002162404 hasConcept C104317684 @default.
• W2002162404 hasConcept C126322002 @default.
• W2002162404 hasConcept C127561419 @default.
• W2002162404 hasConcept C169760540 @default.
• W2002162404 hasConcept C185263204 @default.
• W2002162404 hasConcept C203014093 @default.
• W2002162404 hasConcept C205260736 @default.
• W2002162404 hasConcept C2778389096 @default.

• next